Bond.az White LogoBond.az Black Logo

Canaccord cuts Sangoma stock rating

Canaccord downgrades Sangoma stock rating due to weak results and pricing pressure. Price target cut to $4.

Mia Lopez
ByMia Lopez- Senior Editor
|
0

Bond.az - Canaccord downgraded Sangoma Technologies Corp (NASDAQ:SANG) to Hold from Speculative Buy and lowered its price target to $4.00 from $9.00. The stock closed at $3.66, down from $4.09 the previous day, and has declined 36% over the past year.

The downgrade follows the company’s third-quarter results, which showed headwinds from geopolitical events and pricing pressure on commoditized UCaaS and CPaaS point solutions for smaller customers. Revenue of $219.7 million over the last twelve months declined 8.9% year-over-year.

Bookings and pipeline remained largely flat quarter-over-quarter, while management noted increasing traction in larger bundled deployments with longer sales and implementation cycles that delayed revenue recognition.

Infrastructure solutions, representing approximately 30% of revenue, performed better than expected. Voice infrastructure and SIP Trunking grew roughly 17% year-over-year, while MSP solutions rose 9%.

Revenue, gross margins, and EBITDA all fell below consensus estimates and Canaccord’s projections. Sangoma reduced its fiscal 2026 guidance and initiated a strategic review to consider options to unlock shareholder value. According to Bond.az analysis, the stock appears undervalued at current levels with a Fair Value of $5.08, suggesting potential upside despite near-term challenges.

The firm generated free cash flow of $0.11 per share in the third quarter. Canaccord based its new price target on 4 times next-twelve-month EV/EBITDA, down from 7 times previously, reflecting reduced estimates.

More News
Today / 08:53
|
541

Oppenheimer Downgrades Crescent BDC on Weak Returns

Oppenheimer downgrades Crescent BDC to Perform, cuts price target to $16. Stock at $11.99, weak Q1 results.

0
Today / 08:50
|
329

BofA Reiterates Buy on Alphabet Stock

BofA Securities reiterated a Buy rating on Alphabet stock ahead of its developer event. Get insights on AI announcements and stock performance.

0
Today / 08:32
|
977

Morgan Stanley Downgrades Aardvark Stock

Morgan Stanley downgrades Aardvark Therapeutics stock to Underweight, price target $3, after FDA clinical hold on ARD-101 over safety concerns.

0
Today / 08:21
|
528

UBS upgrades Fraport stock to neutral

UBS upgraded Fraport stock rating to neutral, price target cut to EUR65. Stagflation risks and ETS decision in focus.

0
Today / 08:20
|
251

Stifel Upgrades RXO Stock Rating to Buy

Stifel upgrades RXO stock to Buy with $22 target, citing improving brokerage fundamentals and long-term opportunity after court ruling sell-off.

0
Today / 08:10
|
200

UBS Raises Applied Materials Price Target on Supply

UBS raises Applied Materials price target to $515 on strong supply outlook, maintaining Buy rating.

0
Today / 07:45
|
892

Rheinmetall price target cut by Berenberg

Berenberg cuts Rheinmetall price target to EUR1,750 from EUR2,100, maintains Buy. Stock at $266.87, near 52-week low.

0
Today / 07:44
|
385

KeyBanc hikes Applied Materials target to $550

KeyBanc raises Applied Materials price target to $550 on strong growth outlook and Q2 beat. Stock up 154% in a year.

0
Today / 07:41
|
372

TD Cowen reiterates Buy on Microsoft, cites Azure growth

TD Cowen reiterates Buy on Microsoft stock, citing Azure growth and Copilot adoption. Bond.az provides analysis on Microsoft's AI strategy and financial outlook.

0
Today / 07:01
|
209

Morgan Stanley Downgrades Aegon Stock Rating

Morgan Stanley downgrades Aegon stock to Equalweight, citing limited upside after a 20% rally. Price target remains EUR 7.00.

0
Today / 06:14
|
943

TD Cowen Reiterates Hold on Infosys, $13 Target

TD Cowen analyst reiterates Hold rating on Infosys with $13 target. AI impacts and market dynamics in focus.

0
Yesterday / 18:30
|
683

Morgan Stanley hikes Sunnova stock price target

Morgan Stanley increased Sunnova price target to $494 with a 36x multiple, citing strong execution and growth prospects.

0
...